These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23994876)

  • 1. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs.
    Clouser CL; Bonnac L; Mansky LM; Patterson SE
    Antivir Chem Chemother; 2014 Dec; 23(6):223-30. PubMed ID: 23994876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.
    Clouser CL; Holtz CM; Mullett M; Crankshaw DL; Briggs JE; O'Sullivan MG; Patterson SE; Mansky LM
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1942-8. PubMed ID: 22271861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting drug repositioning for discovery of a novel HIV combination therapy.
    Clouser CL; Patterson SE; Mansky LM
    J Virol; 2010 Sep; 84(18):9301-9. PubMed ID: 20610712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.
    Tsume Y; Incecayir T; Song X; Hilfinger JM; Amidon GL
    Eur J Pharm Biopharm; 2014 Apr; 86(3):514-23. PubMed ID: 24361461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine.
    Clouser CL; Chauhan J; Bess MA; van Oploo JL; Zhou D; Dimick-Gray S; Mansky LM; Patterson SE
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6642-6. PubMed ID: 23010273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A carrier-mediated prodrug approach to improve the oral absorption of antileukemic drug decitabine.
    Zhang Y; Sun J; Gao Y; Jin L; Xu Y; Lian H; Sun Y; Sun Y; Liu J; Fan R; Zhang T; He Z
    Mol Pharm; 2013 Aug; 10(8):3195-202. PubMed ID: 23822717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs?
    Anastasi C; Vlieghe P; Hantz O; Schorr O; Pannecouque C; Witvrouw M; De Clercq E; Clayette P; Dereuddre-Bosquet N; Dormont D; Gondois-Rey F; Hirsch I; Kraus JL
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2459-63. PubMed ID: 12852943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine.
    Damaraju VL; Mowles D; Yao S; Ng A; Young JD; Cass CE; Tong Z
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):236-55. PubMed ID: 22356238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs.
    Wang G; Chen H; Zhao D; Ding D; Sun M; Kou L; Luo C; Zhang D; Yi X; Dong J; Wang J; Liu X; He Z; Sun J
    J Med Chem; 2017 Mar; 60(6):2552-2561. PubMed ID: 28234466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
    Tsume Y; Drelich AJ; Smith DE; Amidon GL
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
    Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
    Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells.
    Ueda K; Masuda A; Fukuda M; Tanaka S; Hosokawa M; Iwakawa S
    Drug Metab Pharmacokinet; 2017 Dec; 32(6):301-310. PubMed ID: 29174536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of bioactive gemcitabine-D-Lys
    Sayyad N; Vrettos EI; Karampelas T; Chatzigiannis CM; Spyridaki K; Liapakis G; Tamvakopoulos C; Tzakos AG
    Eur J Med Chem; 2019 Mar; 166():256-266. PubMed ID: 30716713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.
    Song X; Lorenzi PL; Landowski CP; Vig BS; Hilfinger JM; Amidon GL
    Mol Pharm; 2005; 2(2):157-67. PubMed ID: 15804190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A step further in the SATE mononucleotide prodrug approach.
    Peyrottes S; Villard AL; Coussot G; Augustijns P; Lefebvre I; Aubertin AM; Gosselin G; Périgaud C
    Nucleic Acids Symp Ser (Oxf); 2008; (52):539-40. PubMed ID: 18776492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE
    Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A facile di-acid mono-amidation strategy to prepare cyclization-activating mono-carboxylate transporter 1-targeting gemcitabine prodrugs for enhanced oral delivery.
    Wang Y; Wang G; Chen H; Sun Y; Sun M; Liu X; Jian W; He Z; Sun J
    Int J Pharm; 2020 Jan; 573():118718. PubMed ID: 31756441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
    Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
    Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Antitumor Activity of Monophosphate Ester Prodrugs of Gemcitabine: In Vitro and In Vivo Evaluation.
    Qi H; Lu J; Li J; Wang M; Xu Y; Wang Y; Zhang H
    J Pharm Sci; 2016 Sep; 105(9):2966-2973. PubMed ID: 26994559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
    Immordino ML; Brusa P; Rocco F; Arpicco S; Ceruti M; Cattel L
    J Control Release; 2004 Dec; 100(3):331-46. PubMed ID: 15567500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.